A Comparative Study of Quality of Life in Persons With Irritable Bowel Syndrome and Inflammatory Bowel Disease

Sarah P. Blagden(Churchill Hospital), Lesley Roberts(University of Southampton), Rhonda Lee(Selly Oak Hospital), Sukhdev Singh(Good Hope Hospital), Andrew Soundy(Feed Control (Norway))

Gastroenterology Nursing

January 1, 2015

10.1097/sga.0000000000000124

Cited by 20

Related Papers

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

|Nature reviews. Cancer|2015|1.4k

Weekly dose-dense chemotherapy in first-line epithelial ovarian, fallopian tube, or primary peritoneal carcinoma treatment (ICON8): primary progression free survival analysis results from a GCIG phase 3 randomised controlled trial

|The Lancet|2019|223

Performance status score: do patients and their oncologists agree?

|British Journal of Cancer|2003|222

La-related protein 1 (LARP1) binds the mRNA cap, blocking eIF4F assembly on TOP mRNAs

|eLife|2017|201

Phase I Study of GSK461364, a Specific and Competitive Polo-like Kinase 1 Inhibitor, in Patients with Advanced Solid Malignancies

|Clinical Cancer Research|2011|168